Introduction {#sec1}
============

Fine needle aspiration (FNA) is a well-established tool for the diagnosis of palpable and non-palpable lesions such as those localised to lymph nodes, salivary glands, breast, liver and pancreas, among others. Less enthusiasm is felt for the usage of this technique in the investigation of bone and soft tissue tumours; this is primarily due to their rarity and to difficulties in studying their morphology and obtaining their diagnoses.[@bib1]

Even in specialized centres, where pathologists integrate all the clinical and image information, FNA has not reached the value of trucut biopsy, which is considered the main alternative to incisional biopsy.[@bib1], [@bib2] Several factors are in the basis of the existing scepticism such as the small volume of sample collected, the fact that it only characterizes the sample cytologically, the overlapping of the cytomorphology of various tumours and the large variability of results published in studies over the years.[@bib2]

However, given that it is a less invasive procedure, performed in an outpatient basis without general anaesthesia or hospitalization, as well as having a much lower cost, FNA is an attractive technique when compared to more invasive options. FNA has also the advantage of enabling the aspiration of different parts of a same tumour, which is particularly important in large and heterogeneous neoplasms.

The purpose of this study was to evaluate the diagnostic accuracy of fine-needle biopsy, and to analyse to which extent this method enables the initiation of treatment, clarifying its role in addressing musculoskeletal tumours.

Materials and methods {#sec2}
=====================

One hundred and thirty patients submitted to FNA-derived cell block over a 3-year period were retrospectively reviewed. In the majority of these cases a diagnosis of bone or soft tissue tumour was necessary to start treatment but in a few the exclusion of malignancy was also important. All procedures were performed by one single team (one orthopaedic surgeon and one radiologist) and samples were analysed by the same pathologist.

The average age of the patients was 53.2 years (12--90). There were 59 males and 71 females. Ninety-four underwent bone and 36 soft tissue biopsies. All FNA were performed under image guidance ([Fig. 1](#fig1){ref-type="fig"}). [Table 1](#tbl1){ref-type="table"} depicts the clinical characteristics of the tumours, their anatomical location and the imagiological method used to localize them.Fig. 1Examples of the imagiological methods used for tumour localisation: A) Ultrasonographic view of a soft tissue lesion in the thigh, B) Identification of a bone lesion in the sacrum using CT, C) Identification of a bone lesion in the humerus using X-ray.Fig. 1Table 1Clinical characteristics of bone and soft tissue lesions diagnosed by FNA.Table 1TotalTypeGenderMean age (range)Anatomical locationImage guidance130 biopsiesBone 94Male 5953.2 (12--90)Lower limb 45CT-scan 64Soft tissue 36Female 71Upper limb 22Ultrasonography 36Spine 27Radioscopy 30Pelvis 24Trunk 12

The most suitable route was chosen in order to avoid noble structures such as neurovascular bundles and organs. After the selection of the area, skin was anesthetized with 3--5 ml of 2% Lidocaine and cytoaspiration with a 22-gauge needle was performed. Samples were placed in CytoRich^®^ Red Preservative Fluid and sent to laboratory. The pathologist did not do any preliminary evaluation during the procedure. All samples were centrifuged at 1500 rpm for 10 min, after which the supernatant was discarded. Haematoxylin and Histolgel^®^ were then added and the sample was vortexed for homogenisation. Homogenised sample was then frozen. Frozen tissue was placed in biopsy cassettes and used for histology (Haematoxylin and Eosin) and immunohistochemistry ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2Chordoma of sacrum. A (HE 100×). B (HE 400×). Although "phisaliphorous cells" are not present, epithelioid cells are characteristically arranged as cords and embedded in an extracellular myxoid matrix.Fig. 2

The diagnostic yield (ratio between the number of diagnosis achieved and the number of all procedures) and accuracy (ratio between the confirmed diagnosis and the number of established diagnosis) were evaluated. A diagnosis was considered to be accurate when it was confirmed by histology--trucut biopsy, incisional biopsy, surgery--or ulterior clinical and imaging evaluation as some benign tumours, metastases and hematopoietic lesions do not need histological confirmation. Diagnostic yield and accuracy of soft tissue and bone lesions were analysed and compared. Statistical analysis was performed using GraphPad Prism v. 6.0. The differences between means were compared using *t*-test. A p value \< 0.05 was considered to represent a statistically significant difference.

The minimum follow up was 2 years. Exclusion of malignancy or infection, when clinically suspected, was included in the group of diagnosis.

Results {#sec3}
=======

In 90 patients (69.2%) a diagnosis was obtained and in 87 (96.7%) were accurate. In 36 cases accuracy was confirmed by histology and in 54 cases by clinical and imaging valuation.

In the group of osseous lesions diagnoses were: 28 metastases, 17 primitive malignant tumours, 7 benign tumours, 10 hematologic diseases and 2 infections; in 7 cases pathology could be excluded. In this group only 2 benign lesions were misdiagnosed: a spondylodiscitis of a dorsal vertebra was diagnosed as a Giant Cell Tumour and a low-grade chondrosarcoma of the scapula was assumed as an enchondroma ([Table 2](#tbl2){ref-type="table"}).Table 2Correlation between cytological and final diagnosis in bone and soft tissue tumours.Table 2PatientBone/Soft tissue tumourCytological diagnosisFinal diagnosis1BoneOsteosarcomaOsteosarcoma2BoneBenign lesionEnchondroma3BoneMalignant lesionEwing sarcoma4Soft tissueInconclusiveNeurofibroma5Soft tissueHaemangiomaHaemangioma6BoneMalignant lesionEwing sarcoma7Soft tissueSynovial sarcomaSynovial sarcoma8BoneMetastasisMetastasis9BoneMyelomaMyeloma10BoneBenign lesionOsteoid osteoma11BoneInconclusiveInfection12Soft tissueLymphomaLymphoma13BoneGiant Cell TumourInfection14BoneGiant Cell TumourGiant Cell Tumor15Soft tissueBenignSchwannoma16BoneChondrosarcomaChondrosarcoma17BoneBenign lesionChondromyxoid fibroma18Soft tissueInconclusiveLipoma19BoneChondrosarcomaChondrosarcoma20BoneMyelomaMyeloma21Soft tissueHaemangiomaHaemangioma22BoneInfectionInfection23BoneExclusion tumourExclusion tumour24BoneInconclusiveChondrosarcoma25BoneInconclusiveOsteochondroma26Soft tissueInconclusiveSynovial sarcoma27Soft tissueMyelomaMyeloma28BoneInconclusiveChondrosarcoma29Soft tissueLymphomaLynphoma30Soft tissueInconclusiveMyositis ossificans31Soft tissueBenign lesionHaemangioma32Soft TissueInconclusiveHaemangioma33BoneChondrosarcomaChondrosarcoma34Soft tissueEwing sarcomaEwing sarcoma35BoneInconclusiveHaemangioma36Soft tissueInconclusiveMyxoma37BoneMyelomaMyeloma38BoneChondrosarcomaChondrosarcoma39Soft tissueGanglion cystGanglion cyst40BoneInconclusiveMyeloma41BoneChordomaChordoma42BoneEwing SarcomaEwing Sarcoma43BoneMetastasisMetastasis44BoneMetastasisMetastasis45BoneMetastasisMetastasis46BoneChordomaChordoma47BoneMyelomaMyeloma48BoneEnchondromaChondrosarcoma49BoneGiant Cell TumourGiant Cell Tumour50BoneInfectionInfection51BoneMetastasisMetastasis52BoneMetastasisMetastasis53BoneMetastasisMetastasis54Soft tissueInconclusivoAngiolipoma55BoneMetastasisMetastasis56BoneOsteosarcomaOsteosarcoma57Soft tissueBenign lesionHaemangioma58BoneBenign lesionAneurysmal bone Cyst59Soft tissueLiposarcomaAggressive fibromatosis60BoneBenign lesionAneurysmal bone cyst61Soft tissueLipomaLipoma62Soft tissueInconclusiveSchwannoma63BoneMetastasisMetastasis64BoneBrown tumourBrown tumour65BoneExclusion tumourExclusion tumour66BoneOsteosarcomaOsteosarcoma67BoneExclusion tumourExclusion tumour68BoneAngiosarcomaAngiosarcoma69BoneExclusion tumourExclusion tumour70BoneBenign lesionNon ossifying fibroma71BoneMetastasisMetastasis72BoneMetastasisMetastasis73BoneInconclusiveOsteosarcoma74BoneChondrosarcomaChondrosarcoma75BoneMetastasisMetastasis76Soft tissueLipomaLipoma77BoneMetastasisMetastasis78BoneGiant Cell TumourGiant Cell Tumour79BoneMetastasisMetastasis80Soft tissueLipomaLipoma81BoneOsteosarcomaOsteosarcoma82Soft tissueEwing sarcomaEwing sarcoma83BoneMyelomaMyeloma84BoneInconclusiveInfection85Soft tissueLipomaLipoma86BoneInconclusiveLymphoma87Soft tissueLiposarcomaLiposarcoma88BoneMetastasisMetastasis89BoneMetastasisMetastasis90BoneMetastasisMetastasis91BoneMyelomaMyeloma92BoneChondrosarcomaChondrosarcoma93BoneMetastasisMetastasis94BoneMetastasisMetastasis95BoneExclusion tumourExclusion tumour96BoneMetastasisMetastasis97BoneMyelomaMyeloma98BoneMetastasisMetastasis99BoneMetastasisMetastasis100BoneMetastasisMetastasis101Soft tissueGiant Cell Tumor tendon sheathsGiant Cell Tumor tendon sheaths102BoneMetastasisMetastasis103Soft tissueMyxofibrosarcomaMyxofibrosarcoma104BoneInconclusiveEnchondroma105BoneLymphomaLymphoma106BoneMetastasisMetastasis107Soft tissueInconclusiveLiposarcoma108BoneMyelomaMyeloma109Soft tissueInconclusiveLeiomyosarcoma110BoneInconclusiveMetastasis111Soft tissueMyxomaMyxoma112Soft tissueSchwannomaSchwannoma113BoneGiant Cell TumourGiant Cell Tumour114BoneExclusion tumourExclusion tumour115BoneExclusion tumourExclusion tumour116BoneMyelomaMyeloma117BoneEwing sarcomaEwing sarcoma118BoneInconclusiveChondrosarcoma119BoneMetastasisMetastasis120Soft tissueMalignant lesionLipossarcoma121Soft tissueMalignant lesionLeiomyosarcoma122BoneChondrosarcomaChondrosarcoma123Soft tissueBenign lesionClear cell hidradenoma124BoneInconclusiveOsteosarcoma125BoneMalignant lesionOsteosarcoma126BoneMetastasisMetastasis127BoneInconclusiveEwing sarcoma128BoneMalignant lesionEwing sarcoma129Soft tissueMalignant lesionLipossarcoma130BoneInconclusiveMetastasis

In the group of soft tissue tumours 10 lesions were found to be benign, 6 malignant and 3 were classified as hematologic diseases. In this group an extra abdominal desmoid tumour of the dorsal paravertebral region was wrongly diagnosed as a liposarcoma ([Table 2](#tbl2){ref-type="table"}).

The overall diagnostic yield was 69.2% and the diagnostic accuracy 96.7%. The diagnostic yield for bone lesions alone was 75.5% and that for soft tissue lesions was 52.8% (p = 0.0187). The diagnostic accuracy for bone lesions alone was 97.2% and that for soft tissue lesions was 94.7% (p = 0.5704) -- [Table 3](#tbl3){ref-type="table"}.Table 3Diagnostic yield and diagnostic accuracy in bone and soft tissue tumours. p Values represent the difference between bone and soft tissue tumours.Table 3OverallBone tumoursSoft tissue tumoursp (bone vs soft tissue)Diagnostic yield(90/130) 69.2%(71/94) 75.5%(19/36) 52.8%0.0187Diagnostic accuracy(87/90) 96.7%(69/71) 97.2%(18/19) 94.7%0.05704

FNA was non-diagnostic in 40 cases (30.8%) but in 15 biopsies (11.5%) it was possible to conclude if the lesion was malignant (n = 6) or benign (n = 9) and this information was correct in all cases. It was then considered a completely inconclusive result in 25 cases (19.2%). There were no complications associated with these procedures and all patients were discharged on the same day of the procedure.

Discussion {#sec4}
==========

All cytological results should always be interpreted integrating the clinical and imaging context, which influence the diagnosis regardless of the diagnostic modality chosen. The value of FNA also depends on the operator technique[@bib3] and on the experience of the pathologist.[@bib4]

The first challenge that the FNA faces is obtaining an appropriate sample - checking whether the sample is sufficient in quantity and representative enough to allow for the diagnosis. This point is measured by yield, and values can vary between 3 and 31% of inadequate samples.[@bib2], [@bib5] There are several reasons that help to explain the wide variation of rates, including the type of lesion studied and the accomplishment of preliminary evaluation. The preliminary evaluation comes from the observation of the sample by the pathologist during the procedure, allowing its repetition if necessary, with substantially improved results when compared to studies where this evaluation is not performed.[@bib5], [@bib6] In this study, the quantity and quality of the sample was decided by the executant alone without the presence of the pathologist. Perhaps this was the reason for the poor overall diagnostic yield (69.2%). There are two reasons for a non-diagnostic result. The first is a scant, acellular or artifactually distorted specimen. The second is when the result is incompatible with the clinical and/or image impression.[@bib5], [@bib6] All the 25 completely inconclusive results were due to technical issues with samples. The yield, however, was significantly higher for bone tumours than for soft tissue lesions (p = 0.0187). Again, this difference may be explained by the same two reasons: analysis of tissue architecture and morphology are more important in identifying and distinguishing between soft tissue lesion subtypes and the fact the clinical and imaging information are more informative in the case of bone than in soft tissue lesions.[@bib7]

The accuracy of a diagnostic technique is the most important parameter in its assessment, and obtaining an exact result is its main objective. In different studies, the diagnostic accuracy of FNA varies between 75% and 98%, where the lowest values are obtained in smaller samples.[@bib3], [@bib8], [@bib9] If it were only considered studies with high samples (n \> 300) this value would be greater than 95%.[@bib2], [@bib6], [@bib10], [@bib11], [@bib12] Here, the accuracy was 96,7%, which is even superior to that reported in other studies[@bib3], [@bib9], [@bib11], [@bib13] showing the reliability in the diagnosis of benign tumours, sarcomas, metastases, infections, hematologic disease lesions and in excluding pathology. No significant differences in accuracy were found between soft tissue and bone lesions (p = 0.05704).

In many cases of musculoskeletal tumours, the specific diagnosis has a minor role in the initiation of treatment. The histological grade, staging and anatomical location are the most important factors for therapeutic decisions and it may even be said that the existing protocols are less based on the histological subtype. Some authors go further, referring to the minor importance of histological subtype and highlighting the relevance of the distinction between sarcoma and metastasis, since the treatment of most sarcomas in adults is primarily based on its size, location and proximity to vital structures.[@bib14] Kilpatrick et al[@bib15] considered FNA sufficient to initiate treatment in 83% of soft tissue tumours and in 87% of bone tumours. In a study conducted in 2010, definitive treatment could be initiated based solely on FNA in 81.3% of benign, in 78% of malignant and in 43% of the indeterminate tumours.[@bib12] Assuming the same criteria, the technique in the present study would therefore allow for the initiation of treatment in all 87 patients with a diagnosis proven correct and in the other 9 in which malignancy had been excluded. This would be 96 of the 130 (73.8%) -- [Table 4](#tbl4){ref-type="table"}. Considering the 6 biopsies without diagnosis but with the information of being malignant, 2 were soft tissue lesions. Even in these cases, treatment could have been done, as the great majority of soft tissue sarcoma protocols begin with surgical excision. Moreover, if the treatment had been done according to the 3 wrong diagnoses, in these cases, the final result would not be considered a disaster.Table 4Non-diagnostic results, cases in which a correct diagnosis was established and cases in which treatment was initiated in the overall cohort of patients and also in bone and soft tissue tumours. p Values represent the differences between the mean in bone and soft tissue tumours.Table 4OverallBone tumoursSoft tissue tumoursp (bone vs soft tissue)Non-diagnostic results40/130 30.8%23/94 24.5%17/36 47.2%0.0117Establishing correct diagnosis(87/130) 66.9%(69/94) 73.4%(18/36) 50.0%0.0109Initiating treatment(96/130) 73.8%(74/94) 78.7%(22/36) 61.1%0.0412

Finally, caution should be taken in malignancies since the initial treatment is different according to each diagnosis. The utility of cytogenetics in the routine work-up of sarcomas collected by FNA has been reinforced.[@bib16] It is possible, for instance, to confirm an Ewing sarcoma by the characteristic chromosome translocation t (11, 12) in samples of FNA. Nevertheless this was not done in this study.

In conclusion, despite the low diagnostic yield the accuracy of FNA was very high and would therefore permit the initiation of treatment in most cases, except in those in which the result suggests malignancy without a precise diagnosis.
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